Innospec (IOSP) Scheduled to Post Quarterly Earnings on Thursday

Innospec (NASDAQ:IOSP) will announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of $1.63 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.59 by $0.25. Innospec had a net margin of 7.14% and a return on equity of 13.69%. The business had revenue of $494.70 million for the quarter, compared to the consensus estimate of $479.47 million. During the same period last year, the firm earned $1.20 earnings per share. The company’s quarterly revenue was down 3.1% on a year-over-year basis. On average, analysts expect Innospec to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Innospec Trading Up 2.2 %

IOSP opened at $124.40 on Tuesday. Innospec has a 1-year low of $91.74 and a 1-year high of $131.18. The company has a market capitalization of $3.10 billion, a PE ratio of 22.33 and a beta of 1.11. The firm’s 50 day simple moving average is $123.97 and its two-hundred day simple moving average is $117.04.

Insiders Place Their Bets

In other Innospec news, SVP David B. Jones sold 2,500 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $125.79, for a total value of $314,475.00. Following the transaction, the senior vice president now directly owns 9,664 shares in the company, valued at $1,215,634.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP David B. Jones sold 2,500 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $125.79, for a total transaction of $314,475.00. Following the sale, the senior vice president now directly owns 9,664 shares in the company, valued at approximately $1,215,634.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick Williams sold 9,667 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $124.37, for a total transaction of $1,202,284.79. Following the sale, the chief executive officer now owns 174,334 shares in the company, valued at $21,681,919.58. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 36,500 shares of company stock worth $4,532,959. Company insiders own 1.35% of the company’s stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.